👉 The Baron Global Advantage Fund returned 22.7% in the second quarter, outperforming the MSCI ACWI Index and the MSCI ACWI Growth Index.
👉 The fund highlighted stocks such as Illumina, Inc. (NASDAQ:ILMN), a leading supplier of sequencing- and array-based solutions for genetic and genomic analysis.
👉 Illumina, Inc. (NASDAQ:ILMN) generated approximately $1.06 billion in revenue in the second quarter, reaching the upper end of its guidance range.